North America Pacemaker Market

North America Pacemaker Market Size (2023 to 2028)

The North American Pacemaker Market is estimated to rise at a CAGR of 3.55% during the forecast period. The size of the market is estimated to grow USD 1.94 billion by 2028 from USD 1.63 billion in 2023.

A pacemaker is an electrical device used to treat arrhythmias, which cause an irregular heartbeat. If the patient suffers from arrhythmia, the heart is weak to pump enough blood to other parts of the body, causing fatigue and fainting.

The increasing prevalence of cardiovascular disorders primarily drives the North American pacemaker market in developed countries, high incidence of diseases in underdeveloped countries, various supporting government initiatives, and funding from non-governmental organizations. The factors driving the pacemaker market are the latest diagnostics, a favorable reimbursement scenario for the treatment, and the cost-effective actions taken by various governments. The increasing prevalence of cardiovascular disease in both developed and developing economies worldwide is expected to generate strong demand in the North American pacemaker market during the forecast period.

Cardiac arrest is the leading cause of death worldwide each year. For example, according to a study by the American Heart Association, Inc., in 2020, more than 4.83,000 Americans die of cardiac arrest in a single year and of which more than 3.75,000 occur outside of the heart hospital. It can lead to the growth of the global market. Besides, low lifestyle, extreme stress, unhealthy and hereditary eating habits, and various other reasons are responsible for the increased heart rate. It has created a dire state for countries worldwide to attempt to control the death rate from cardiac arrest, which will ultimately increase the demand for pacemakers in the North American market.

Besides, pacemakers are widely adopted as a treatment method by doctors and surgeons worldwide for their reliability. Governments have also encouraged people to undergo pacemaker treatments by charging them low taxes and providing them with pacemakers at a subsidized rate.

The high cost and lack of knowledge about pacemakers are expected to slow the North American pacemaker market growth during the forecast period. Also, the availability of alternative treatments to pacemaker technology is also likely to hamper the development of the North American market.

This research report on the North America Pacemaker Market has been segmented and sub-segmented into the following categories:

 By Product:

• Implantable
• External Pacemakers

By Application:

• Unipolar
• Bipolar Pacemakers

By Country:

• The United States
• Canada
• Rest of North America

Geographically, the Global Pacemaker Devices market was dominated by North America due to increasing cardiac diseases and various technological advancements happening in the research area. North America is estimated to be the dominant market of the global pacemaker market in 2019 due to the robust healthcare infrastructure and the high prevalence of the cardiovascular disease. Pacemakers can control and restore normal electrical pathways in the human heart and help prevent severe and life-threatening cardiovascular arrests in high-risk patients. Therefore, the adoption of these devices increases with technological innovation and the increase in the incidence and prevalence of chronic cardiovascular disease and associated deaths worldwide. For example, according to the American Heart Association, cardiovascular disease is the leading cause of death regionally, with more than 400,000 deaths in 2019. This number is estimated to rise to over 800,000 million by 2050.

Notable companies dominating the North America Pacemaker Market profiled in this report are Medtronic, Sorin Group, Biotronik GmbH & Co. KG., Boston Scientific Corporation, Vitatron, St. Jude Medical, Inc., and Zoll Medical Corporation